Skip to content
DraconiticResearch
Search Sources API
220,472 studies31 sourcesUpdated 41 min ago

Oncology

5,770 studies495 in 7 days2,675 in 30 days

Filters
Type
Date
Clear

Latest

5,770 studies

  1. Pharmacologic Targeting of ZNF281 Suppresses Metastatic Prostate Cancer Beyond Androgen Receptor Dependence
    G. Huang, M. A. Lorenzana Carrillo, H. Chen +14
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. Temporal N-terminomics analysis reveals proteome remodeling following brensocatib-mediated cathepsin C inhibition in promyeloblast cells
    Y. Zhu, S. Luedtke, B. Xu +5
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  3. Mitochondrial rewiring supports survival of triple negative breast cancer cells after ionizing radiation
    S. W. Wall, K. Wang, A. Greer +14
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  4. Cell cycle control of chromatin creates a therapeutic window for epigenetic therapy in tumors
    K. Hayatigolkhatmi, R. Valzelli, E. Ceccacci +25
    bioRxivPreprintCC BY-NDFull textOncologybioRxiv
  5. HSPD1 promotes neuroblastoma by augmenting MYCN expression
    S. S. Alassam, D. B. Manikandan, H. Ben-David +9
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  6. Tumor-intrinsic IFNγ signaling and niche adaptation drive early colonization in ovarian cancer metastasis.
    Emilija Aleksandrovic, Shaneann R Fross, Samantha M Golomb +16
    Nature communicationsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  7. Towards Democratizing CNS Tumor Classification: 10-fold reduction in methylation sequencing cost with the Flongle Flow Cell
    A. Grunwald, G. Feinberg-Gorenshtein, H. Toledano +3
    medRxivPreprintCC BY-NCFull textOncologymedRxiv
  8. Genetic predictors of clonal contraction and hematologic response in IDH mutant myeloid malignancies
    A. Song, Y. Chen, S. Iyer +18
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  9. ⁶⁸Ga-FAPI-04 PET/CT has high diagnostic efficacy in Tg-positive and Tg-negative differentiated thyroid cancer
    Lixian Mou, Ting Zhang, Xiaoling Zhang +3
    PLOS OnePeer-reviewedCC BY 4.0Full textMedical imaging & radiologyOncologyPLOS
  10. Nintedanib in the prevention of radiation-induced lung injury in patients with unresectable stage II-III NSCLC: A protocol for a randomized, multicenter, control group study
    Ai Cui, Anhui Shi, Lei Deng +4
    PLOS OnePeer-reviewedCC BY 4.0Full textMedical imaging & radiologyOncologyPLOS
  11. Colorectal Lesion diagnosis using transformer and deep learning with multiscale feature interface
    Dhirendra Prasad Yadav, Bhisham Sharma, Julian L. Webber +1
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPhysiologyPLOS
  12. Comprehensive analysis of non-synonymous single-nucleotide polymorphism of human TSC1 and TSC2 genes: An in silico approach
    Tasnim Alam, Shangida Akther
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  13. Deceptive bias measurement in deep learning: Assessing shortcut reliance in TCGA cancer models
    Farnaz Kheiri, Shahryar Rahnamayan, Masoud Makrehchi
    PLOS Digital HealthPeer-reviewedCC BY 4.0Full text1 citedOncologyPLOS
  14. Lung cancer risk prediction using interpretable ensemble models on lifestyle and clinical data
    Shahid Mohammad Ganie, Pijush Kanti Dutta Pramanik, Zhongming Zhao
    PLOS OnePeer-reviewedCC BY 4.0Full textNutritionOncologyPLOS
  15. Pediatric opioid and cannabis poisoning hospitalizations in the United States, 2016–2022: a national age-matched inpatient analysis
    Linor Fournier, Shereen Shehadeh, Mohamad Hamad Saied +2
    Frontiers in PediatricsPeer-reviewedCC BY 4.0Full textOncologyHAL
  16. Unveiling the immune microenvironment in sinonasal intestinal type adenocarcinoma: new arguments for immunotherapy
    Charles Lépine, Cécile Deleine, Richard Danger +7
    OncoImmunologyPeer-reviewedCC BY-NC 4.0Full textOncologyHAL
  17. The effect of adapted physical activity programs on the regulation of emotions in people suffering from major depressive disorders after hospital discharge : REAPAD study protocol
    Cathy Longuechaud, France Videau Villeneuve, Francis Bulteau +5
    Minerva psychiatryPeer-reviewedCC BY-NC 4.0Full text2 citedOncologyHAL
  18. An inertial-based spiral device for separating rare tumor cells from liquid biopsies
    Isidora Panez‐Toro, Laurent Griscom, Dominique Heymann +1
    Bioengineering & Translational MedicinePeer-reviewedCC BY 4.0Full textOncologyHALPMC
  19. Renal cell carcinoma: molecular understanding and therapeutic development
    Tao Hou, Xiangmei Hua, Wei Ni +3
    Cell death and differentiationPeer-reviewedLicence not statedFull textOncologyPMC
  20. Castration‐resistant prostate cancer cells are addicted to the high activity of cyclin‐dependent kinase 2
    Joyeeta Chatterjee, Alessia Marin, Shivani Yalala +1
    Molecular OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  21. Beyond Remission: Risk-Adapted Maintenance and Mechanism-Guided Salvage After CAR T-Cell Therapy for Multiple Myeloma
    Shuai Su, Sijia Yan, Jiaying Wu +1
    Stem Cell Reviews and ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  22. A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA2131
    Jennifer R. Eads, Ju-Whei Lee, Cheng E. Chee +6
    Clinical colorectal cancerPeer-reviewedCC BY-NC-NDFull textOncologyPMC
  23. Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards
    Yu Fujiwara, Shumei Kato, Razelle Kurzrock
    Hematology/Oncology Clinics of North AmericaPeer-reviewedLicence not statedFull text23 citedOncologyOpenAlex
  24. Visualizing the distribution of durvalumab targeting PD-L1 using quantitative fluorescence imaging in patients with esophageal cancer.
    Anne M van der Waaij, Ymke J van Ginkel, Pia Volkmer +14
    TheranosticsPeer-reviewedCC BYFull textOncologyEurope PMC
  25. A CD109-SMURF2 Axis Diverts EGFR from Degradation to Sustain Oncogenic Signaling and Promote Squamous Cell Carcinoma Invasion and Stemness
    T. Kungyal, A. Hassan, K. Finnson +2
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv